Status:
COMPLETED
Quality of Life Influencing Factors
Lead Sponsor:
Peking University People's Hospital
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18-75 years
Brief Summary
Background: quality of life is impaired in patients with paroxysmal atrial fibrillation. The purpose of this study is to explore the mediating effects of self-efficacy, coping, depression, and anxiety...
Eligibility Criteria
Inclusion
- age 18-75 years;
- AF diagnosis, based on a 12-lead ECG and cardiologist-led examination following the 2016 ESC Guidelines for the Management of Atrial Fibrillation
- paroxysmal AF diagnosis given by a cardiologist according to the conversion back to the normal sinus rhythm occurs spontaneously within a week
- ability to read and write in Chinese.
Exclusion
- severe complications such as unstable coronary artery disease, heart failure with severe systolic dysfunction(ejection fraction≤35%)
- AF soon after thoracic surgery;
- malignant disease with a 1-year survival rate or a terminal illness diagnosis;
- a diagnosed psychiatric condition that interfered with participation (including severe depression, bipolar disorder, psychotic illness of any type, dementia, acute suicidality, severe personality disorder)
- participation in another study
- cognitive impairment interfering with their ability to participate in the study
Key Trial Info
Start Date :
March 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT05974098
Start Date
March 10 2020
End Date
May 1 2023
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shan Qu
Beijing, Beijing Municipality, China, 100044